Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 52.40
+0.50 (0.96%)
At close: Jan 1, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.63 billion as of January 2, 2026. Its market cap has increased by 7.38% in one year.
Market Cap
5.63B
Enterprise Value
9.65B
Revenue
9.52B
Ranking
n/a
PE Ratio
10.51
Stock Price
52.40
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.63B, an increase of 98.48%. That is a compound annual growth rate of 23.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 5.63B | 0.96% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 348.24B |
| Square Pharmaceuticals PLC. | 176.85B |
| Robi Axiata PLC. | 147.71B |
| British American Tobacco Bangladesh Company | 134.24B |
| BRAC Bank PLC. | 125.63B |
| Walton Hi-Tech Industries | 125.59B |
| Bangladesh Export Import Company | 103.85B |
| Marico Bangladesh | 84.22B |